≡ Search

logo - Farma Industria Ticino

  • Home
  • Members
  • News
  • Events
  • Contact
  • About us
  • Jobs
  • IT

Main activities

  • Licensing-In
  • Licensing-Out
  • Co-development
  • Trading
  • Drug Product CMO
  • Drug Substance CMO
  • Other CMO Activities

Other activities

  • Analytical Services
  • Cosmetics
  • Distribution
  • Feed Additives
  • Flavours and Fragrances
  • Medical Devices
  • Medical Food
  • Natural Products
  • Nutraceuticals
  • Pre-formulation

2013

Helsinn Group’s representative office in China: Official inauguration

4 December 2013

Helsinn and Chugai Pharma Marketing enter into agreement for rights of Anamorelin, currently in development for treatment of anorexia-cachexia syndrome related to non-small cell lung cancer in top EU markets

12 November 2013

10 young students from the Sopraceneri area receive Helsinn Advanced Synthesis SA 2013/2014 educational scholarships

9 October 2013

Helsinn to launch sales organization in the United States

4 October 2013

Very positive Clinical Phase I/IIa results for Calcipotriol AKVANO formulation for the treatment of Psoriasis

13 September 2013

Helsinn Group and Eisai Inc. Announce Top-Line Results for Pivotal Studies of the Investigational Fixed-Dose Combination of Netupitant and Palonosetron for Prevention of Chemotherapy-Induced Nausea and Vomiting

16 May 2013

NEWSOur new plant for CHO based mAb or Recombinant Protein manufacturing is ready for the qualification phase

19 February 2013

BAK - The economic portrait of Ticino’s life science sector

Progetto Talenti

Cultura e salute

  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
Also on:
Linkedin
  • Education
  • Contact
  • Restricted area
  • About us

©2025 Farma Industria Ticino

Made by plastical

Loading...